BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7805020)

  • 21. Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens.
    Gautherot E; Le Doussal JM; Bouhou J; Manetti C; Martin M; Rouvier E; Barbet J
    J Nucl Med; 1998 Nov; 39(11):1937-43. PubMed ID: 9829586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bifunctional HBED-derivative for labeling of antibodies with 67Ga, 111In and 59Fe. Comparative biodistribution with 111In-DPTA and 131I-labeled antibodies in mice bearing antibody internalizing and non-internalizing tumors.
    Schuhmacher J; Klivényi G; Hull WE; Matys R; Hauser H; Kalthoff H; Schmiegel WH; Maier-Borst W; Matzku S
    Int J Rad Appl Instrum B; 1992 Nov; 19(8):809-24. PubMed ID: 1428911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenolic aminocarboxylic acids as gallium-binding radiopharmaceuticals.
    Hunt FC
    Nuklearmedizin; 1984 Jun; 23(3):123-5. PubMed ID: 6435093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.
    Rogers BE; Anderson CJ; Connett JM; Guo LW; Edwards WB; Sherman EL; Zinn KR; Welch MJ
    Bioconjug Chem; 1996; 7(4):511-22. PubMed ID: 8853465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
    Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 68Ga-labeled oligonucleotides for in vivo imaging with PET.
    Roivainen A; Tolvanen T; Salomäki S; Lendvai G; Velikyan I; Numminen P; Välilä M; Sipilä H; Bergström M; Härkönen P; Lönnberg H; Långström B
    J Nucl Med; 2004 Feb; 45(2):347-55. PubMed ID: 14960659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen.
    Kang N; Hamilton S; Odili J; Wilson G; Kupsch J
    Clin Cancer Res; 2000 Dec; 6(12):4921-31. PubMed ID: 11156253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
    Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
    J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
    Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography.
    Schottelius M; Poethko T; Herz M; Reubi JC; Kessler H; Schwaiger M; Wester HJ
    Clin Cancer Res; 2004 Jun; 10(11):3593-606. PubMed ID: 15173065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice.
    Krohn KA; Meyers JM; DeNardo GL; DeNardo SJ
    J Nucl Med; 1977 Mar; 18(3):276-81. PubMed ID: 65460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability, targeting, and biodistribution of scandium-46- and gallium-67-labeled monoclonal antibody in erythroleukemic mice.
    Anderson WT; Strand M
    Cancer Res; 1985 May; 45(5):2154-8. PubMed ID: 3857116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of 67Ga uptake to citrate dose, compared with 67Ga-chloride and 67Ga-transferrin in rodent tissues and tumours.
    Hammersley PA; Zivanovic MA
    Nuklearmedizin; 1980 Feb; 19(1):25-8. PubMed ID: 7402941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colon carcinoma immunoscintigraphy by monoclonal anti-CEA antibody labeled with gallium-67-aminooxyacetyldeferroxamine.
    Ryser JE; Jones RM; Egeli R; Pélegrin A; Rose K; Kurt AM; Perin M; Broquet PE; Ambrosetti P; Fisch I
    J Nucl Med; 1992 Oct; 33(10):1766-73. PubMed ID: 1403142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting very small model lesions pretargeted with bispecific antibody with 99mTc-labeled high-specific radioactivity polymers.
    Tekabe Y; Einstein AJ; Johnson LL; Khaw BA
    Nucl Med Commun; 2010 Apr; 31(4):320-7. PubMed ID: 20087237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.
    Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Saga T; Konishi J; Yamamuro T
    Cancer Res; 1988 Mar; 48(5):1189-94. PubMed ID: 3422590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pretargeting of renal cell carcinoma: improved tumor targeting with a bivalent chelate.
    Boerman OC; Kranenborg MH; Oosterwijk E; Griffiths GL; McBride WJ; Oyen WJ; de Weijert M; Oosterwijk-Wakka J; Hansen HJ; Corstens FH
    Cancer Res; 1999 Sep; 59(17):4400-5. PubMed ID: 10485489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of competitive binding of gallium and iron by tumor cells.
    Anghileri LJ; Crone-Escanye MC; Thouvenot P; Robert J
    Nuklearmedizin; 1984 Dec; 23(6):327-9. PubMed ID: 6597918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.